Open Access

What works to meet the sexual and reproductive health needs of women living with HIV/AIDS

Journal of the International AIDS Society201114:56

https://doi.org/10.1186/1758-2652-14-56

Received: 9 April 2011

Accepted: 18 November 2011

Published: 18 November 2011

Abstract

It is critical to include a sexual and reproductive health lens in HIV programming as most HIV transmission occurs through sexual intercourse. As global attention is focusing on the sexual and reproductive health needs of women living with HIV, identifying which interventions work becomes vitally important. What evidence exists to support sexual and reproductive health programming related to HIV programmes?

This article reviews the evidence of what works to meet the sexual and reproductive health needs of women living with HIV in developing countries and includes 35 studies and evaluations of eight general interventions using various methods of implementation science from 15 countries. Data are primarily from 2000-2009. Searches to identify effective evaluations used SCOPUS, Popline, Medline, websites and consultations with experts. Evidence was ranked using the Gray Scale.

A range of successful and promising interventions to improve the sexual and reproductive health and rights of women living with HIV include: providing contraceptives and family planning counselling as part of HIV services; ensuring early postpartum visits providing family planning and HIV information and services; providing youth-friendly services; supporting information and skills building; supporting disclosure; providing cervical cancer screening; and promoting condom use for dual protection against pregnancy and HIV. Provision of antiretrovirals can also increase protective behaviours, including condom use.

While many gaps in programming and research remain, much can be done now to operationalize evidence-based effective interventions to meet the sexual and reproductive health needs of women living with HIV.

Review

Meeting women's sexual and reproductive health (SRH) needs ensures women have control over their reproductive lives, as well as contributes to public health by reducing maternal and infant morbidity and mortality [1]. Yet the SRH needs of women are compelling: 215 million women in the developing world have an unmet need for family planning [2]. Women who have unintended pregnancies are affected by biological outcomes, such as increased maternal morbidity and mortality, as well as social outcomes, such as stigma. Of the 215 million women with an unmet need for family planning, it is unclear how many are HIV positive or of unknown serostatus.

Women living with HIV, as well as HIV-negative women, would benefit from interventions that meet their SRH needs and reduce unintended pregnancies, reduce HIV transmission and acquisition, and reduce reproductive morbidity and mortality. One study found that HIV-positive women are five times more likely to have a high-risk type of human papillomavirus (HPV) [3], and therefore are at increased risk of cervical cancer.

Further, a study in Uganda found that unintended pregnancies may account for almost a quarter of all HIV-positive infants in that country [4]. A 2008 modelling study in the 15 US President's Emergency Plan for AIDS Relief (PEPFAR) countries estimated that the annual number of unintended HIV-positive births averted by contraception use is more than 220,000 [5].

As a sexually transmitted infection, HIV is inextricably linked with women's sexual and reproductive health; at least half of the 2.6 million new infections globally in 2009 were among women [6]. Unfortunately, discussions of SRH services for women living with HIV often revolve around controlling fertility and ignore HIV-positive women's needs for services that include attention to safe and healthy sexuality and a desire for children. Women living with HIV must "have the right to decide freely and responsibly on the number and spacing of their children" [7].

Over the past several years, a number of international agencies have called for stronger links between reproductive health and family planning and HIV/AIDS programmes and services [8, 9] and have issued guidance on linkages and integration within global AIDS programmes [1013]. As global attention is focusing on the SRH needs of women living with HIV, identifying which interventions work to meet those needs becomes vitally important. With scarce resources and growing demand for services, programme priorities must be based on effective interventions. One key question, therefore, must be answered: what is the evidence for effective interventions to meet the SRH needs of women living with HIV?

This paper reviews successful and promising interventions to meet the SRH needs of women and girls living with HIV, based on a more extensive review of the evidence to support interventions for women and girls related to all aspects of HIV and AIDS programming [14]. This review article focuses on SRH interventions for women living with HIV based largely on research and programme evaluations conducted in developing country settings, so as to be most relevant for developing country settings. Realistic interventions may differ between resource-rich and resource-poor settings.

The paper: 1) analyzes the breadth of interventions and the strength of the evidence; 2) describes successful and promising interventions to reduce unintended pregnancy, to reduce HIV transmission, and to reduce reproductive morbidity and mortality; and 3) provides recommendations for strengthening programmes to meet SRH needs.

Our approach

The review focused on areas of SRH that are of critical concern to women living with HIV in developing countries: reducing unintended pregnancy; promoting safer sex and the ability of HIV-positive women to have wanted children while reducing the likelihood of transmission to a sexual partner (which includes issues of disclosure); and reducing the incidence of cervical cancer in HIV-positive women. Safe motherhood, including use of antenatal, delivery and postnatal care, and prevention of vertical transmission of HIV is a critical issue in the sexual and reproductive rights of women living with HIV, but it is outside the scope of this paper.

To search for relevant interventions, SCOPUS [15] searches were conducted for 2005-2009 using the search words HIV or AIDS and wom*n, and other specific terms, including "sexual rights and HIV"; "sexual health and HIV"; family planning and HIV"; "contraception and HIV"; and "cervical cancer and HIV." Earlier material was identified using the same search terms in Popline and Medline. In addition, the gray literature was captured through review of websites: Center for Reproductive Rights; Engenderhealth; FHI360; Guttmacher Institute; HRW; ICW; International HIV/AIDS Alliance; IPAS; IPPF; NIH; OSI, PAI; UNAIDS, and WHO. In addition, experts were consulted on each topic, both to ensure complete coverage of the topic and to review the evidence included in the analysis. Altogether, more than sixty experts were consulted on comprehensiveness, applicability and accuracy; experts included researchers who had published widely on this topic, women living with HIV who belong to advocacy organizations, policymakers, program managers and donors. Those who attended a review meeting were asked 10 questions related to the evidence in the chapters they were reviewing. Other experts were sought out to provide technical detail and understanding; those questions were tailored for their area of expertise and to the outstanding queries of the authors. To be included in this review, the SRH interventions had to have an evaluation (either the intervention was part of a study or it was subject to an evaluation) with outcomes reported with sex-disaggregated data, where relevant.

Evidence was rated using the Gray Scale [16], which lists five levels of evidence, with I being the strongest and V the weakest (Table 1). In the case of conference abstracts, only abstracts from recent AIDS and family planning conferences were included and only abstracts of strong studies that, once published, will likely be Gray I, II or III. Criteria set for "what works," and "promising" interventions, shown in Table 2 were determined by an expert review panel [14].
Table 1

Gray scale of the strength of evidence

Type

Strength of evidence

I

Strong evidence from at least one systematic review of multiple well-designed, randomized controlled trials.

II

Strong evidence from at least one properly designed, randomized controlled trial of appropriate size.

III

Evidence from well-designed trials without randomization: single, group, pre-post, cohort, time series, or matched case-control studies.

IV

Evidence from well-designed, non-experimental studies from more than one centre or research group.

V

Opinions of respected authorities, based on clinical evidence, descriptive studies or reports of expert committees.

Table 2

Criteria for "what works" and "promising" Interventions

Type

Criteria

What works

Strongly rated studies (Gray I, II or III) for at least two countries and/or five weaker studies across multiple settings.

Promising

Studies that were strongly rated but in only one setting or a number of weaker studies in only one country.

This review includes 35 studies and/or evaluations grouped under eight interventions (Table 3). Of the eight interventions, six fall under the category of what works, while two fall into the category of promising. The interventions included evidence from 15 individual countries, all in Africa, Latin America and the Caribbean, and the US, as well as from analyses of multiple countries and regions (Table 3).
Table 3

Evidence to support interventions for promoting the sexual and reproductive health of women living with HIV/AIDS, by study

Intervention

Outcomes

Reference

Country

G*

Description

Contraception/

FP as part of routine HIV services and vice versa

Increase condom, contraceptive and dual method use, avert unintended pregnancies, increase

VCT

[17]

Zambia

II

FP^ education and offer of contraceptives available on site rather than by referral.

  

[18]

South Africa

II

Integrated routine discussion of HIV risk and prevention, dual method use and increased counselling and testing in FP services.

  

[19]

Haiti

III

Rapid HIV testing performed on all pregnant women. After testing, all HIV-positive, pregnant women informed of their status, counselled and referred to ANC clinic. Voluntary counselling and testing (VCT), sexually transmitted infections (STIs), family planning (FP) services and TB screening and treatment integrated into one central HIV clinic.

  

[20]

Kenya

III

Trained staff on contraceptive methods with job aids to use with clients; provision of free contraceptive methods; appointment cards; discussions with couples; involvement of male partners in discussions; and discussions of unintended pregnancies.

  

[21]

Kenya

III

Provider-initiated testing and counselling with updated guidelines to discuss HIV transmission, conduct risk assessment, discuss dual protection, and offer testing and counselling. Staff training included contraception, HIV, reproductive rights, informed choice, safe sex, values clarification, risk assessment and reduction, record keeping and logistics.

  

[22]

Nigeria

III

Integration of FP and HIV services, with strengthened referral links, provider training, co-located services, same staff and parallel supply chain management systems and strong monitoring and evaluation.

  

[23]

Uganda

III

FP was integrated into HIV treatment, using an integrated training curriculum. Short-term contraceptives were available on site with referral for long-term and permanent methods.

  

[24]

Uganda

IV

Access to contraception and linking FP services for women on HAART.

  

[25]

Uganda

V

Easy access to FP services for HIV-positive women accessing HAART services

  

[26]

Malawi

V

Providing on-site FP services to women participating in HIV-related research studies.

  

[27]

South Africa

V

Women initiating ART also counselled on effective contraception, provided through referral to a nearby primary care clinic.

Early postpartum visits that include FP and HIV information and services

Increased condom use, contraceptive use, HIV testing and treatment, reduced unintended pregnancy

[38]

Swaziland

III

One week postpartum visit for HIV-positive mothers, with provider training on FP.

  

[39]

Kenya

III

Postpartum follow up for HIV-positive women, with referral for contraceptive counselling and services. The women were counselled antenatally to initiate contraception postpartum and dual protection.

  

[40]

Cote d'Ivoire

III

Women tested for HIV prenatally were followed up for two years following delivery. At each postpartum visit, women received FP counselling and free contraception.

Providing clinic services that are youth-friendly

Increased use of reproductive health service, including counselling and testing

[41]

Multi-country

III

A review of HIV prevention interventions among youth from 80 developing countries.

  

[42]

Mozambique

III

Youth-friendly clinical services as part of a multidisciplinary approach that include no-cost FP counselling and contraceptives and HIV counselling and testing.

  

[43]

Madagascar

III

Offer of confidential, convenient and affordable HIV testing, FP and STI treatment services by non-judgmental providers. Promotion of the clinics through mass media, face-to-face communication and mobile outreach.

Providing information and skills-building support for HIV-positive people

Reduce unprotected sex

[44]

USA

I

A meta-analytic review of 12 trials in the US. All interventions provided information with nine interventions providing skill building through live demonstrations, role plays or practice, such as correct use of condoms, coping or interpersonal skills, such as communication about safer sex or disclosing serostatus. Interventions were delivered by healthcare providers, counsellors or trained HIV-positive peers. Effective interventions were delivered on a one-to-one basis by providers or counsellors with at least 10 intervention sessions for at least three months. No studies which met the meta-analytic criteria were found for developing country contexts.

  

[45]

Multi-country

I

A meta-analysis found that the most effective interventions included skills-building and motivated participants.

  

[46]

Multi- country

III

A review of interventions for "prevention for positives" included: individually delivered intervention sessions; group sessions, including a focus on gender and sexual orientation; attention to negative consequences of unsafe sex for the HIV-positive person; interactive group sessions and social networking. Addressing provider attitudes and providing training to providers was found to be critical.

  

[47]

Zambia

V

Focus group sessions for women with skills training on HIV prevention and transmission, communication, conflict resolution and sexual negotiation.

Supporting disclosure

Increase condom use among discordant couples

[48]

South Africa

IV

To assess outcomes associated with disclosure, including safer sexual behaviour.

  

[49]

Uganda

Abs

A programme by The AIDS Support Organization (TASO) to provide support that resulted in sero-disclosure.

  

[50]

Caribbean Region

Abs

Assessed disclosure and relevant outcomes, including condom use.

Providing ARVs

Increase prevention behaviours, including condom use

[53]

Uganda

III

Study participants were followed in a home-based ART programme that included prevention counselling, VCT for cohabitating partners and condom provision.

  

[54]

Uganda

III

A prospective cohort of HIV-negative household members of HIV-positive patients on ART receiving home-based care.

  

[55]

Kenya

III

A comparative study of people living with HIV or AIDS on HAART and those receiving preventative therapy (PT), including such outcomes as condom use.

  

[56]

Uganda

III

Condom use among ART patients compared with non-ART patients.

  

[57]

Multi-country

III

To assess outcomes among ART patients compared with non-ART patients, including condom use.

  

[58]

Rwanda and Zambia

IV

A study of longitudinal data from sero-discordant couples, including unprotected sex, condom use and pregnancy.

  

[59]

Brazil, South Africa and Uganda

IV

Analysis of survey data of HIV-positive women in three countries, including HAART and condom use.

  

[60]

Mozambique

IV

A survey of HIV care clinic attendees from initiation to treatment, including condom use.

Promising

Cervical cancer screening integrated into HIV care

Reduce morbidity and mortality in women living with HIV

[63]

Zambia

V

A programme for cervical cancer for both HIV-positive and HIV-negative women that screened more than 20,000 women and linked cervical cancer prevention services with HIV care and treatment services. Cervical cancer using visual inspection with acetic acid (VIA) provided on-the-spot results, which were then linked with same-visit cryotherapy. Peer educators reduced loss to follow up. Community women were trained on conducting community-based cervical health promotion talks. Women who wanted more information were directed to the cervical cancer prevention clinics. To minimize stigma, screening clinics were co-located in government-operated public health clinics near to but not directly within the HIV clinic.

  

[64]

NA

V

A new, rapid HPV test is underway and may be the best option considering the difficulties associated with Pap smears, visual inspection and HPV tests in low-resource countries. Questions remain on effectiveness in HIV-positive women.

Promoting condom use for contraception

Make condom use more acceptable and easier to negotiate

[65]

Ethiopia

III

A study that included assessment of use of condoms and reasons for condom use among sex workers.

Total

35

   

* G = Gray Scale Rating of the Strength of the Evidence (see Table 1)

^ FP = family planning

Abs = abstract

Interventions that work

Promoting contraceptives and family planning counselling as part of routine HIV services and vice versa

Eleven studies and/or evaluations (see Table 3) provided evidence that promoting contraceptives and family planning as a routine part of HIV services (and vice versa) may increase condom use, contraceptive use and dual method use [1727]. Providing these integrated services can avert unintended pregnancies among women living with HIV. For example, successful outcomes have been demonstrated in Haiti and Zambia using family planning education, offering contraceptives on site at a voluntary counselling and testing (VCT) clinic, increased counselling and provision of free contraceptives, as well as involving male partners in discussions of unintended pregnancies and integration of services [17, 19].

In Haiti, GHESKIO (The Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections, a non-governmental organization providing training, research and services) integrated VCT and family planning services in one central HIV clinic. At 18 months, 74% of the 348 HIV-positive mothers in the study were using family planning services compared with 23% of women in the general population [19]. A three-arm randomized trial at a VCT clinic in Lusaka, Zambia, with 251 couples found a threefold higher contraceptive initiation rate where family planning was available on site, rather than by referral to an outside clinic [17].

Because many people still do not know their HIV status, and because negotiating condom use is not always possible, expanding access to a range of contraceptives for all women who need and want them is an important component of HIV programming, and it is cost effective [28, 29].

In providing integrated services, both providers and clients need up-to-date information on contraceptives and HIV. No current method of contraception protects against HIV transmission; contraception and condom use together can provide the best "dual protection" against conception and HIV transmission. Over the years, questions have arisen about the safety of use of hormonal contraceptives by women living with HIV and whether any contraceptive methods increase the risk of HIV acquisition. Multi-country reviews found that hormonal and intrauterine methods of contraception were generally well tolerated by women with HIV [30] and found no association between hormonal contraceptive use and HIV disease progression [31].

A study in Uganda of 625 women with 13 years of follow up found no association between hormonal contraception and increased risk of death for women living with HIV [32]. A review performed by an independent expert group using 1000 references related to IUDs found no known drug interactions between IUDs and highly active antiretroviral therapy (HAART) [33]. The review also determined that there appears to be no increase in overall complications, although HIV-positive women need to be screened for sexually transmitted infections with IUDs [33]. There was no increased risk of transmission to HIV-negative partners by HIV-positive IUD users.

Biological and epidemiological data have suggested that hormonal contraceptive use could influence HIV acquisition, but not all studies have shown this relationship and "many questions remain" [34]. A re-analysis of earlier data using more sophisticated modeling found that DPMA use was marginally associated with an increased risk of HIV acquisition while oral contraceptive use was not; however, young women under age 24 using DPMA were at increased risk of HIV acquisition [35]. A recent analysis of data from east and southern Africa from the Partners in Prevention HSV/HIV Transmission Study found an elevated risk of HIV acquisition for women and transmission from women to men, with hormonal contraceptive use [36]. The World Health Organization (WHO) is convening a technical review meeting of hormonal contraception and HIV in January 2012. Until the evidence is further evaluated, WHO's Medical Eligibility Criteria for Contraceptive Use recommends that the benefits of hormonal contraceptive use outweigh any potential harm for women at high risk of and living with HIV [37].

Early postpartum visits that include FP and HIV information and services

Contraception counselling for women in order to space their next pregnancy or prevent an unintended pregnancy is a critical component of postpartum care. Evaluations of interventions in three countries showed that postpartum services can result in increased condom and contraceptive use, HIV testing and treatment, and reduced unintended pregnancy [3840]. In Swaziland, a study with 356 postpartum women and 53 healthcare workers that instituted a one week post-delivery postpartum visit along with provider training from 2006 to 2007 found that the proportion of HIV-positive postpartum women not wanting another child increased from 77% to 83% [38]. Provider training increased the proportion of women being asked about their preferred contraceptive method, from 32% to 82%, and receiving their preferred method, from 28% to 70%. Male partners who tested for HIV increased from 28% to 56%.

Providing clinic services that are youth friendly

Young people's service needs are frequently overlooked in HIV programming that is not specifically for young people. A review in 80 developing countries found that youth-friendly services increased young people's use of health services [41]. Interventions in two countries, Mozambique and Madagascar, show that services that include confidential, non-judgemental, convenient and affordable HIV testing and counselling and family planning information and services can increase use of services by youth [42, 43].

Providing information and skills-building support can reduce unprotected sex

Most data on this topic come from the United States [4447]. Only one of the studies was with HIV-positive women only, and this was in Zambia [47]. A meta-analytic review of 12 randomized trials in the USA found interventions (described in Table 3) that are effective in reducing unprotected sex and acquisition of sexually transmitted infections among people living with HIV [44]. A meta-analysis of 14 articles with studies that included 3324 HIV-positive people, most in the USA, found that motivational and behavioural skills building concerning sexual risks increased condom use [45].

A number of studies in the USA also found that interactive group sessions, frequency of counselling and disclosure reduced unprotected sex [46]. In the developing world, one study in Zambia with 180 women found safer sex skills training on HIV prevention and transmission, communication, conflict resolution and sexual negotiation resulted in female participants reporting increased condom use, with 94% of the women reporting using condoms all of the time [47].

Supporting disclosure can increase safer sexual behaviour

Three studies in the review showed that women who feel support for disclosure exhibit safer sexual behaviours [4850]. For example, one study in South Africa found that among 177 HIV-positive people who disclosed, perceived support for disclosure led to safer sexual behaviour: 82% asked their partners to get tested, 64% used condoms, 56% reduced their numbers of sexual partners, and 20% abstained from sex. Family members and providers were the main sources of social support [48].

Providing ARVs and counselling increases HIV prevention behaviours

Studies, including modeling, have shown that antiretroviral (ARV) therapy reduces HIV transmission [51, 52]. A study assessing HIV transmission among 1763 serodiscordant couples where the HIV-positive partner was initiated on ARV therapy when CD4+ counts were between 350 and 500 cells/mm3 showed such compelling results that it was stopped early. The study showed a 96% reduction in transmission to the HIV-negative partner [52]. Eight studies in this review show that providing antiretroviral treatment to people living with HIV, along with counselling on safer sex, can increase HIV prevention behaviours, including condom use [5360]. For example, a study in Uganda found that within six months of initiating ART, inconsistent or no condom use was reduced by 70% [53].

Another study in Uganda of 182 men and 273 women found that both men and women on antiretroviral therapy (ART) reduced inconsistent condom use from 29% to 15%. Among women, risky sex decreased from 31% at baseline to 10% at six months and 15% at 24 months; among men, risky sex decreased from 30% at baseline to 8% at six months and 13% at 24 months [54]. Analysis of survey data of 85 HIV-positive women from Uganda, 50 HIV-positive women from South Africa and 44 HIV-positive women from Brazil found that HAART users were 3.64 times more likely to use condoms [59]. A survey of 277 patients in Mozambique found that after one year of ART, 77% were more likely to report correct and consistent condom use compared with 33% prior to initiation [60]. The study also showed the need to continue prevention messages as both men and women had an increase in the number of partners, including partners with HIV-negative or unknown serostatus.

Promising strategies

Cervical cancer screening and treatment can be integrated into HIV care

Women living with HIV are at high risk of developing cervical cancer [61], yet coverage for screening in many developing countries is low [62]. While only reaching the level of promising evidence, a programme in Zambia screened 20,000 women in 15 primary care clinics and linked cervical cancer prevention services with HIV treatment and care [63]. Another study suggests that cervical cancer screening of HIV-positive women in low-resource countries could be integrated with ARV treatment, as ART programmes have established the regular observation, infrastructure and services to support cervical cancer screenings. Development of a new, rapid HPV test is underway and may be the best option considering the difficulties associated with Pap smears, visual inspection and HPV tests in low-resource countries [64].

Promoting condoms for contraception as well as HIV prevention may make condoms more acceptable

Promoting condoms for contraception may increase condom use, although clients should also be counselled that there are other methods of contraception that are more effective in preventing unintended pregnancy. A study of 372 sex workers in Ethiopia found that those women who used condoms for contraception were more likely to use condoms consistently (65% compared with 24%) [65].

Conclusions

Identifying the links between SRH and HIV is a timely issue: in addition to this analysis [14], several reviews have recently been published [66, 67] and several international agencies, including the Global Fund to Fight AIDS, Tuberculosis and Malaria and PEPFAR, have issued guidance on strengthening ties between reproductive health, family planning and HIV/AIDS programmes and services.

The evidence reviewed in this paper covers successful and promising interventions that programmes can implement to improve the sexual and reproductive health and rights of women living with HIV. Provision of ARV, critical for the lives of women living with HIV, can also increase protective behaviours, including condom use. Additionally, other effective interventions to help meet the SRH needs of women living with HIV include: provision of contraceptives and family planning counselling as part of HIV services; ensuring that providers and women have evidence-based information on a range of contraceptive methods and HIV; supporting information and skills building; supporting disclosure; providing cervical cancer screening; and promoting condom use for dual protection against pregnancy and HIV infection. The evidence base is supported by studies throughout the world and tends to rest on well-designed, non-randomized studies (Gray III). Given that it would not be possible to conduct randomized control trials (Gray II) on many aspects of HIV and SRH, the level of evidence that exists is sufficiently strong to promote SRH and HIV programming.

For all that is known about promoting SRH, many gaps in programming and research remain. A critical gap remains with the question of hormonal contraception and HIV. According to Morrison and Nanda, "The question of hormonal contraceptive use and risk of HIV acquisition remains unanswered after more than two decades ... the time to provide a more definitive answer to this crucial public health question is now; the donor community should support a randomized trial of hormonal contraception and HIV acquisition" [68].

More programming is needed to expand access to contraceptive information and care, provided by trained providers adhering to rights-based approaches to service provision. Policies are needed, including those supporting integrated services. Other interventions, such as transforming gender norms, reducing violence against women, promoting legal rights and increasing employment opportunities, also need to be implemented in order to support safer sexual behaviour [14].

The strength of this review is that: these interventions emerged from a comprehensive review of the evidence; the evidence was rated using a clear methodology that was endorsed by a scientific review committee; and the review makes scientific evidence accessible to non-scientific audiences.

The analysis also contains some limitations. Unsuccessful interventions are not published. Many worthwhile interventions do not have sex-disaggregated data or are not thoroughly evaluated, and still others are not published in peer-reviewed journals or are not published at all. Some important work from the gray literature may have been missed. One weakness of the Gray scale is prioritizing randomized controlled trials, which are "primarily a vehicle for evaluating biomedical interventions, rather than strategies to change human behaviour. Altering the norms and behaviours of social groups can sometimes take considerable time ..." [69]. Furthermore, randomized controlled trials are not appropriate for certain HIV interventions and therefore should not be the only factor in judging the relative weight of any particular study. In addition, many HIV prevention programmes that address key issues in novel, context-specific ways are often not rigorously evaluated [70].

The interventions highlighted in this review are, for the most part, implemented on a small scale. It will be important to scale up the interventions to reach all relevant women and girls. The review has identified interventions that have demonstrated success in certain settings and particular countries. However, implementation of the interventions highlighted in this review as "what works" or "promising" must be contextually specific and culturally appropriate if they are to be translated to new settings. It is therefore difficult to be direct about exactly how each of these interventions will work best (for example, how to support disclosure). But there is enough evidence to show that certain ideas and approaches do have a demonstrated effect on behaviour across multiple settings.

Given that the AIDS epidemic is approaching 30 years, it time to redouble efforts to ensure that programmes meet the SRH needs of women living with HIV and to deepen the evidence base of the most appropriate and successful interventions to do so [71].

A new generation is now reaching reproductive age, making the need for strong evidence-based SRH services as part of HIV programmes all the more critical.

Authors' information

JG has worked at the US Institute of Medicine and served on the IRB of NIAID. She has consulted for PAHO, the World Bank, USAID, UN Women, UNPFA and others.

KH, Senior Fellow at the Futures Group, has worked extensively with bilateral, multilateral and country-level organizations on international family planning and reproductive health policy and programme issues, including integration with HIV/AIDS programmes.

MCG is an independent consultant specializing in public education strategies to improve the sexual and reproductive health of women and men worldwide.

CH is working towards an MSc in Epidemiology at the London School of Hygiene and Tropical Medicine.

List of abbreviations

AIDS: 

acquired immune deficiency syndrome

ART: 

antiretroviral therapy

ARV: 

antiretroviral

CD4: 

cluster of differentiation 4, type of white blood cell which HIV infects, low CD4 counts signify low immunity

DMPA: 

depot medroxyprogesterone acetate, also known as Depo-Provera, a long-term injection hormonal contraceptive

GHIESKO: 

Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes

HAART: 

highly active antiretroviral therapy

HIV: 

human immunodeficiency virus

IPPF: 

International Planned Parenthood Federation

IUD: 

intrauterine device

PEPFAR: 

US President's Emergency Plan for AIDS Relief

SRH: 

sexual and reproductive health

VCT: 

voluntary counselling and testing

UNAIDS: 

United Nations Programme on HIV/AIDS

UNFPA: 

United Nations Population Fund

USAID: 

US Agency for International Development

WHO: 

World Health Organization.

Declarations

Acknowledgements

This review was based on What Works for Women & Girls: Evidence for HIV/AIDS Interventions http://www.whatworksforwomen.org, which received funding from the Open Society Institute and from PEPFAR through the USAID-funded Health Policy Project. The views expressed in this article do not necessarily represent the views of the US Government.

Authors’ Affiliations

(1)
J. Gay and Associates, LLC
(2)
Futures Group
(3)
Artemis Global Consulting
(4)
London School of Hygiene and Tropical Medicine

References

  1. Wilcher R, Cates W: Reproductive choices for women with HIV. Bull World Health Organ 2009,87(11):833–839.PubMedView ArticleGoogle Scholar
  2. Singh S, Darroch JE, Ashford LS, Vlassoff M: Adding it Up: The Costs and Benefits of Investing in Family Planning and Maternal and Newborn Health. New York: Guttmacher Institute and United Nations Population Fund; 2009.Google Scholar
  3. Moodley JR, Hoffman M, Carrara H, Allan BR, Cooper DD, Rosenberg L, Denny LE, Shapiro S, Williamson AL: HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. BMC Cancer 2006, 6:135.PubMedView ArticleGoogle Scholar
  4. Hladik W, Stover J, Esiru G, Harper M, Tappero J: The contribution of family planning towards the prevention of vertical HIV transmission in Uganda. PLoS ONE 2009,4(11):e7691.PubMedView ArticleGoogle Scholar
  5. Reynolds HW, Janowitz B, Wilcher R, Cates W: Contraception to prevent HIV-positive births: current contribution and potential cost savings in PEPFAR countries. Sex Transm Infect 2008,84(Suppl 2):ii49-ii53.PubMedView ArticleGoogle Scholar
  6. UNAIDS Global Report: [http://www.unaids.org/en/resources/presscentre/factsheets/] Fact Sheet: The Global AIDS Epidemic.
  7. The United Nations' Division for the Advancement of Women: Convention on the elimination of all forms of discrimination against women. New York: CEDAW; 1979.Google Scholar
  8. Africa Union: Maputo Plan of Action for the Operationalisation of the Continental Policy Framework for Sexual and Reproductive Health and Rights 2007–2010. Addis Ababa; 2006.Google Scholar
  9. UNFPA: The Glion Call to Action on Family Planning and HIV/AIDS in Women and Children: 3–5 May 2004. Geneva: UNFPA; 2004.Google Scholar
  10. WHO, UNFPA, IPPF and UNAIDS: Sexual and Reproductive Health & HIV/AIDS: A Framework for Priority Linkages. Geneva: WHO; 2005.Google Scholar
  11. WHO: HIV Technical Briefs: Strengthening Linkages Between Family Planning and HIV: Reproductive Choices and Family Planning for People Living with HIV. Geneva: WHO; 2007.Google Scholar
  12. USAID: [http://www.usaid.gov/our_work/global_health/pop/techareas/fphiv.html] Family Planning and HIV Prevention Integration.
  13. Hardee K, Gay J, Dunn-Georgiou E: A Practical Guide to Integrating Reproductive Health and HIV/AIDS into Grant Proposals to the Global Fund. Washington, DC: Population Action International; 2009.Google Scholar
  14. Gay J, Hardee K, Croce-Galis M, Kowalski S, Gutari C, Wingfield C, Rovin K, Berzins K: [http://www.whatworksforwomen.org/] What Works for Women and Girls: Evidence for HIV/AIDS Interventions. New York: Open Society Institute; 2010;
  15. SCOPUS [http://info.scopus.com/scopus-in-detail/facts/]
  16. Gray JAM: Evidence Based Health Care: How to Make Health Policy and Management Decisions. London: Churchill Livingstone; 1997.Google Scholar
  17. Mark KE, Meinzen-Derr J, Stephenson R, Haworth A, Ahmed Y, Duncan D, Westfall A, Allen S: Contraception among HIV concordant and discordant couples in Zambia: a randomized controlled trial. J Womens Health 2007,16(8):1200–1210.View ArticleGoogle Scholar
  18. Mullick S, Menziwa M, Mosery N, Khoza D, Maroga E: Feasibility, Acceptability, Effectiveness and Cost of Models of Integrating HIV Prevention and Counseling and Testing for HIV within Family Planning Services in North West Province, South Africa. Washington, DC: Population Council; 2008.Google Scholar
  19. Deschamps MM, Noel F, Bonhomme J, Devieux JG, Saint-Jean G, Zhu Y, Wright P, Pape JW, Malow RM: Prevention of mother-to-child transmission of HIV in Haiti. Rev Panam Salud Publica 2009,25(1):24–30.PubMedView ArticleGoogle Scholar
  20. Ngure K, Heffron R, Mugo N, Irungu E, Celum C, Baeten JM: Successful increase in contraceptive uptake among Kenyan HIV-1-serodiscordant couples enrolled in an HIV-1 prevention trial. AIDS 2009,23(Suppl 1):S89-S95.PubMedView ArticleGoogle Scholar
  21. Liambila W, Askew I, Mwangi J, Ayisi R, Kibaru J, Mullick S: Feasibility and effectiveness of integrating provider-initiated testing and counseling within family planning services in Kenya. AIDS 2009,23(Suppl 1):S115-S121.PubMedView ArticleGoogle Scholar
  22. Chabikuli NO, Awi DD, Chukwujekwu O, Abubakar Z, Gwarzo U, Ibrahim M, Merrigan M, Hamelmann C: The use of routine monitoring and evaluation systems to assess a referral model of family planning and HIV service integration in Nigeria. AIDS 2009,23(Suppl 1):S97-S103.PubMedView ArticleGoogle Scholar
  23. Searing H, Farrell B, Gutin S, Johri N, Subramaian L, Kakande H, Nagendi G, Randiki M, Masita-Mwangi M: Evaluation of a Family Planning and Antiretroviral Therapy Integration Pilot in Mbale, Uganda. New York: The ACQUIRE Project and USAID; 2008.Google Scholar
  24. Andia I, Kaida A, Maier M, Guzman D, Emenyonu N, Pepper L, Bangsberg DR, Hogg RS: Highly active antiretroviral therapy and increased use of contraceptives among HIV-positive women during expanding access to antiretroviral therapy in Mbarara, Uganda. Am J Public Health 2009,99(2):340–347.PubMedView ArticleGoogle Scholar
  25. Ssewankambo F, Naluga C, Namale G, Luatalo I, Kambugo A: [https://www.conftool.com/fpconference2009/index.php?page=browseSessions&form_session=26&presentations=show&abstracts=show] Determinants of contraceptive use among HIV infected women attending care in an urban center [abstract]. International Conference on Family Planning: 15–18 Nov 2009; Muyonyo, Uganda;
  26. Kachipapa E, Mphande C, Potani C, Kayoyo V, Maseko B, Mawindo P, Kadiwa M, Mvalo T, Chibwe J, Hoffman I, Hoseinipour M, Martinson F: Uptake of family planning among Malawian women participating in HIV related research studies [abstract]. The XVII International AIDS Conference: 3–8 Aug 2008; Mexico City, Mexico;Google Scholar
  27. Myer L, Reber K, Morroni C: Missed opportunities to address reproductive health care needs among HIV-infected women in antiretroviral therapy programmes. Trop Med Int Health 2007,12(12):1484–1489.PubMedView ArticleGoogle Scholar
  28. Adair T: Unmet need for contraception among HIV-positive women in Lesotho and implications for mother-to-child transmission. J Biosoc Sci 2009,41(2):269–278.PubMedView ArticleGoogle Scholar
  29. Halperin DT, Stover J, Reynolds HW: Benefits and costs of expanding access to family planning programs to women living with HIV. AIDS 2009,23(Suppl 1):S123-S130.PubMedView ArticleGoogle Scholar
  30. Curtis KM, Nanda K, Kapp N: Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review. AIDS 2009,23(Suppl 1):S55-S67.PubMedView ArticleGoogle Scholar
  31. Stringer EM, Giganti M, Carter RJ, El-Sadr W, Abrams EJ, Stringer JS: Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative. AIDS 2009,23(Suppl 1):S69-S67.PubMedView ArticleGoogle Scholar
  32. Polis CB, Gray RH, Bwanika JB, Kigozi G, Kiwanuka N, Nalugoda F, Kagaayi J, Lutalo T, Serwadda D, Wawer MJ: Effect of hormonal contraceptive use before HIV seroconversion on viral load setpoint among women in Rakai, Uganda. J Acquir Immune Defic Syndr 2011,56(2):125–130.PubMedView ArticleGoogle Scholar
  33. Castaño PM: Use of intrauterine devices and systems by HIV-infected women. Contraception 2007,75(suppl 6):S51. Cited in Martinez F, Lopez-Arregui E: Infection Risk and Intrauterine Devices. Acta Obstet Gynecol Scand2009, 88(3):246–250PubMedView ArticleGoogle Scholar
  34. Baeten JM, Lavreys L, Overbaugh J: The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis 2007,45(3):360–369.PubMedView ArticleGoogle Scholar
  35. Morrison CS, Chen PL, Kwok C, Richardson BA, Chipato T, Mugerwa R, Byamugisha J, Padian N, Celentano DD, Salata RA: Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 2010,24(11):1778–1781.PubMedView ArticleGoogle Scholar
  36. Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, de Bruyn G, Nakku-Joloba E, Ngure K, Kiarie J, Coombs RW, Baeten JM, for the Partners in Prevention HSV/HIV Transmission Study Team: Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis, in press.Google Scholar
  37. WHO, Department of Reproductive Health and Research: [http://whqlibdoc.who.int/hq/2011/WHO_RHR_11.28_eng.pdf] Statement on the Heffron et al study on the safety of using hormonal contraceptives for women at risk of HIV infection.
  38. Warren C, Shongwe R, Waligo A, Mahdi M, Mazia G, Narayanan I: Repositioning Postnatal Care in a High HIV Environment: Swaziland. Washington, DC: Horizons Program/Population Council, Elizabeth Glaser Pediatric AIDS Foundation, BASICS, Central Statistics Office Swaziland; 2008.Google Scholar
  39. Balkus J, Bosire R, John-Stewart G, Mbori-Ngacha D, Schiff MA, Wamalwa D, Gichuhi C, Obimbo E, Wariua G, Farquhar C: High uptake of postpartum hormonal contraception among HIV-1 seropositive women in Kenya. Sex Transm Dis 2007,34(1):25–29.PubMedView ArticleGoogle Scholar
  40. Brou H, Viho I, Djohan G, Ekouevi DK, Zanou B, Leroy V, Desgrees-du-Lou A pour le groupe Ditrame Plus ANRS 1202/1201/1253: Contraceptive use and incidence of pregnancy among women after HIV testing in Abidjan, Ivory Coast. Rev Epidemiol Sante Publique 2009,57(2):77–86.PubMedView ArticleGoogle Scholar
  41. Ross DA, Dick B, Ferguson J: Preventing HIV in Young People: A Systematic Review of Evidence from Developing Countries. Geneva: WHO; 2006.Google Scholar
  42. Melo J, Folgosa E, Manjate D, Osman N, Francois I, Temmerman M, Cappuccinelli P, Colombo MM: Low prevalence of HIV and other sexually transmitted infections in young women attending a youth counselling service in Maputo, Mozambique. Trop Med Int Health 2008,13(1):17–20.PubMedView ArticleGoogle Scholar
  43. Neukom J, Ashford L: Changing Youth Behavior Through Social Marketing: Program Experiences and Research Findings from Cameroon, Madagascar, and Rwanda. Washington, DC: Population Reference Bureau and Population Services International; 2003.Google Scholar
  44. Crepaz N, Lyles CM, Wolitski RJ, Passin WF, Rama SM, Herbst JH, Purcell DW, Malow RM, Stall R, HIV/AIDS Prevention Research Synthesis Team: Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS 2006,20(2):143–157.PubMedView ArticleGoogle Scholar
  45. Johnson BT, Carey MP, Chaudoir SR, Reid AE: Sexual risk reduction for persons living with HIV: research synthesis of randomized controlled trials, 1993 to 2004. J Acquir Immune Defic Syndr 2006,41(5):642–650.PubMedView ArticleGoogle Scholar
  46. Gilliam PP, Straub DM: Prevention with positives: a review of published research, 1998–2008. J Assoc Nurses AIDS Care 2009,20(2):92–109.PubMedView ArticleGoogle Scholar
  47. Jones DL, Ross D, Weiss SM, Bhat G, Chitalu N: Influence of partner participation on sexual risk behavior reduction among HIV-positive Zambian women. J Urban Health 2005,82(3 Suppl 4):iv92-iv100.PubMedGoogle Scholar
  48. Wong LH, Van Rooyen HV, Modiba P, Richter L, Gray G, McIntyre JA, Schetter CD, Coates T: Test and tell: correlates and consequences of testing and disclosure of HIV status in South Africa (HPTN 043 Project Accept). J Acquir Immune Defic Syndr 2009,50(2):215–222.PubMedView ArticleGoogle Scholar
  49. Kadando R, Lyavala J, Mulongo M: Sero status disclosure in HIV prevention: encouraging results from TASO Tororo [abstract]. The XVII International AIDS Conference: 3–8 Aug 2008; Mexico City, Mexico;Google Scholar
  50. Allen C, Simon Y, Edwards J, St. Bernard P: Factors associated with condom use in the Caribbean Regional Network of People Living with HIV/AIDS (CRN+) [abstract]. The XVII International AIDS Conference: 3–8 Aug 2008; Mexico City, Mexico;Google Scholar
  51. Attia S, Egger M, Muller M, Zwahlen M, Low N: Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009, 23:1397–1404.PubMedView ArticleGoogle Scholar
  52. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makherma J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielson-Saines K, Celentano D, Essex M, Fleming TR, for the HTPN 052 Study Team: Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011,365(6):493–505.PubMedView ArticleGoogle Scholar
  53. Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, Were W, Coutinho A, Liechty C, Madraa E, Rutherford G, Mermin J: Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 2006,20(1):85–92.PubMedView ArticleGoogle Scholar
  54. Bechange S, Bunnell R, Awor A, Moore D, King R, Mermin J, Tappero J, Khana K, Bartholow B: Two-year follow-up of sexual behavior among HIV-uninfected household members of adults taking antiretroviral therapy in Uganda: no evidence of disinhibition. AIDS Behav 2008,14(4):816–823.PubMedView ArticleGoogle Scholar
  55. Sarna A, Luchters SM, Geibel S, Kaai S, Munyao P, Shikely KS, Mandaliya K, van Dam J, Temmerman M: Sexual risk behavior and HAART: a comparative study of HIV-infected persons on HAART and on preventive therapy in Kenya. Int J STD AIDS 2008,19(2):85–89.PubMedView ArticleGoogle Scholar
  56. Bateganya M, Colfax G, Shafer LA, Kityo C, Mugyenyi P, Serwadda D, Mayanja H, Bangsberg D: Antiretroviral therapy and sexual behavior: a comparative study between antiretroviral-naïve and -experienced patients at an urban HIV/AIDS care and research center in Kampala, Uganda. AIDS Patient Care STDs 2005,19(11):760–768.PubMedView ArticleGoogle Scholar
  57. Kennedy C, O'Reilly K, Medley A, Sweat M: The impact of HIV treatment on risk behaviour in developing countries: a systematic review. AIDS Care 2007,19(6):707–20.PubMedView ArticleGoogle Scholar
  58. Sullivan P, Kayitenkore K, Chomba E, Karita E, Mwanayanda L, Vwalika C, Conkling M, Luisi N, Tichacek A, Allen S: Reduction of HIV transmission risk and high risk sex while prescribed ART: results from discordant couples in Rwanda and Zambia [abstract]. The 16th Conference on Retroviruses and Opportunistic Infections: 8–11 Feb 2009; Montreal, Canada;Google Scholar
  59. Kadia A, Gray G, Bastos FI, Andia I, Maier M, McIntyre J, Grinsztejn B, Strathdee SA, Bangsberg DR, Hogg R: The relationship between HAART use and sexual activity among HIV-positive women of reproductive age in Brazil, South Africa, and Uganda. AIDS Care 2008,20(1):21–25.View ArticleGoogle Scholar
  60. Pearson CR, Cassels S, Kurth AE, Montoya P, Micek MA, Gloyd SS: Change in sexual activity 12 months after ART initiation among HIV-positive Mozambicans. AIDS Behav 2011,15(4):778–787.PubMedView ArticleGoogle Scholar
  61. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA: Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 2009,101(16):1120–1130.PubMedView ArticleGoogle Scholar
  62. Gakidou E, Nordhagen S, Obermeyer Z: Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med 2008,5(6):e132.PubMedView ArticleGoogle Scholar
  63. Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP: Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. AIDS 2009,23(6):N1–5.PubMedView ArticleGoogle Scholar
  64. Franceschi S, Jaffe H: Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy. Clin Infect Dis 2007,45(4):510–513.PubMedView ArticleGoogle Scholar
  65. Aklilu M, Messele T, Tsegaye A, Biru T, Mariam DH, van Benthem B, Coutinho R, Rinke de Wit T, Fontanet A: Factors Associated with HIV-1 Infection among Sex Workers of Addis Ababa, Ethiopia. AIDS 2001,15(1):87–96.PubMedView ArticleGoogle Scholar
  66. Brickley DB, Almers L, Kennedy CE, Spaulding AB, Mirjahangir J, Kennedy GE, Packel L, Osborne K, Mbizvo M, Collins L: Sexual and reproductive health services for people living with HIV: a systematic review. AIDS Care 2011,23(3):303–14.PubMedView ArticleGoogle Scholar
  67. Kennedy CE, Spaulding AB, Brickley DB, Almers L, Mirjahangir J, Packel L, Kennedy GE, Mbizvo M, Collins L, Osborne K: Linking sexual and reproductive health and HIV interventions: a systematic review. J Int AIDS Soc 2010, 13:26.PubMedView ArticleGoogle Scholar
  68. Morrison CS, Nanda K: Hormonal contraception and HIV: an unanswered question. Lancet Infect Dis, in press.Google Scholar
  69. Global HIV Prevention Working Group: Behavior Change and HIV Prevention: [Re]Considerations for the 21st Century. Seattle: Gates Foundation; 2008.Google Scholar
  70. Gupta GR, Parkhurst JO, Ogden JA, Aggleton P, Mahal A: Structural approaches to HIV prevention. Lancet 2008,372(9640):764–775.PubMedView ArticleGoogle Scholar
  71. Padian NS, Holmes CB, McCoy SI, Lyerla R, Buoey PD, Goosby EP: Implementation science for the US President's Emergency Plan for AIDS Relief (PEPFAR). J Acquir Immune Defic Syndr 2011,56(3):199–203.PubMedView ArticleGoogle Scholar

Copyright

© Gay et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement